Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Sturfelt

Showing results (81-90 of 178) with videos related to

Pageof 18
Sort By:
British Journal of Rheumatology|December 1, 1989
Lung function in patients with systemic lupus erythematosus and persistent chest symptomsH Jonsson, O Nived, G Sturfelt, et al.
Rheumatology (Oxford, England)|November 8, 2002
Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortalityA Jönsen, A A Bengtsson, O Nived, et al.
British Journal of Rheumatology|February 4, 1998
Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosusG Sturfelt, P Roux-Lombard, F A Wollheim, et al.
Clinical and Experimental Immunology|March 24, 2009
Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cellsB Gullstrand, U Mårtensson, G Sturfelt, et al.
Clinical and Experimental Immunology|September 1, 1990
Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupusL Nässberger, A G Sjöholm, H Jonsson, et al.
Clinical and Experimental Rheumatology|September 1, 1995
Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosusH Jonsson, G Sturfelt, U Mårtensson, et al.
Rheumatology (Oxford, England)|May 16, 2002
Risk factors for developing systemic lupus erythematosus: a case-control study in southern SwedenA A Bengtsson, L Rylander, L Hagmar, et al.
Lancet (London, England)|March 4, 1989
Circulating anti-elastase in systemic lupus erythematosusL Nässberger, H Jonsson, A G Sjöholm, et al.
The Journal of Rheumatology|February 1, 1996
C1 inhibitor deficiency in a patient with rheumatoid arthritis--increased risk of adverse effects of penicillamine?G Sturfelt, L Rydgren, L Truedsson, et al.
Journal of Clinical & Laboratory Immunology|June 1, 1988
Complement fixation by solid phase immune complexes. Reduced capacity in SLE seraG Baatrup, H Jonsson, A Sjöholm, et al.
Pageof 18

Showing results (81-90 of 178) with videos related to

Sort By:
Pageof 18
British Journal of Rheumatology|December 1, 1989
Lung function in patients with systemic lupus erythematosus and persistent chest symptomsH Jonsson, O Nived, G Sturfelt, et al.
Rheumatology (Oxford, England)|November 8, 2002
Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortalityA Jönsen, A A Bengtsson, O Nived, et al.
British Journal of Rheumatology|February 4, 1998
Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosusG Sturfelt, P Roux-Lombard, F A Wollheim, et al.
Clinical and Experimental Immunology|March 24, 2009
Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cellsB Gullstrand, U Mårtensson, G Sturfelt, et al.
Clinical and Experimental Immunology|September 1, 1990
Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupusL Nässberger, A G Sjöholm, H Jonsson, et al.
Clinical and Experimental Rheumatology|September 1, 1995
Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosusH Jonsson, G Sturfelt, U Mårtensson, et al.
Rheumatology (Oxford, England)|May 16, 2002
Risk factors for developing systemic lupus erythematosus: a case-control study in southern SwedenA A Bengtsson, L Rylander, L Hagmar, et al.
Lancet (London, England)|March 4, 1989
Circulating anti-elastase in systemic lupus erythematosusL Nässberger, H Jonsson, A G Sjöholm, et al.
The Journal of Rheumatology|February 1, 1996
C1 inhibitor deficiency in a patient with rheumatoid arthritis--increased risk of adverse effects of penicillamine?G Sturfelt, L Rydgren, L Truedsson, et al.
Journal of Clinical & Laboratory Immunology|June 1, 1988
Complement fixation by solid phase immune complexes. Reduced capacity in SLE seraG Baatrup, H Jonsson, A Sjöholm, et al.
Pageof 18